Dr. Michael A Rausch
Claim this profileGSK Investigational Site
Studies Respiratory Syncytial Virus
Studies Flu
10 reported clinical trials
13 drugs studied
Affiliated Hospitals
Clinical Trials Michael A Rausch is currently running
GSK4532990
for Fatty Liver Disease
The purpose of this study is to understand how the drug GSK4532990 is processed in the body (pharmacokinetics) and how it works in the liver (pharmacodynamics) as well as to ensure it is safe and well-tolerated. The total study duration for each participant will be approximately 24 weeks.
Recruiting1 award Phase 24 criteria
New Vaccine
for Flu
The aim of this study is to evaluate the safety, reactogenicity and immunogenicity of the Flu Pandemic messenger RNA (mRNA) vaccine (including dose-finding and dose-confirmation) administered healthy adults 18 to 85 years of age.
Recruiting0 awards Phase 1 & 23 criteria
More about Michael A Rausch
Clinical Trial Related4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Michael A Rausch has experience with
- RSVPreF3 OA Vaccine
- Orforglipron
- Insulin Glargine
- Gepotidacin
- Nitrofurantoin
- Meningococcal MenACWY Conjugate Vaccine (GSK3536820A) (MenA Lyo + MenCWY Liquid)
Breakdown of trials Michael A Rausch has run
Respiratory Syncytial Virus
Chronic Kidney Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael A Rausch specialize in?
Michael A Rausch focuses on Respiratory Syncytial Virus and Flu. In particular, much of their work with Respiratory Syncytial Virus has involved treating patients, or patients who are undergoing treatment.
Is Michael A Rausch currently recruiting for clinical trials?
Yes, Michael A Rausch is currently recruiting for 4 clinical trials in El Dorado Kansas. If you're interested in participating, you should apply.
Are there any treatments that Michael A Rausch has studied deeply?
Yes, Michael A Rausch has studied treatments such as RSVPreF3 OA vaccine, Orforglipron, Insulin Glargine.
What is the best way to schedule an appointment with Michael A Rausch?
Apply for one of the trials that Michael A Rausch is conducting.
What is the office address of Michael A Rausch?
The office of Michael A Rausch is located at: GSK Investigational Site, El Dorado, Kansas 67042 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.